The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials Nature
RSV tied to high complication, death rates in hospitalized older adults CIDRAP
Respiratory Illnesses Data Channel Centers for Disease Control and Prevention | CDC (.gov)
3 Million More Older Adults Set to Get RSV Vaccine on NHS European Medical Journal
RSV is still spreading, prompting states to extend the immunization period CNN
Respiratory viruses lingering longer than usual this year The Hill
Texas extends RSV vaccine season as infections remain high. Here’s what you need to know KERA News
As RSV evolves, a two‑pronged antibody cocktail aims to stay ahead Medical Xpress
Respiratory Syncytial Virus Vaccines Market To 2035 Fueled by Expansion of Adult Immunization Schedules - News and Statistics IndexBox
Pueblo County child dies of RSV, is first RSV death in over 5 years Pueblo Chieftain
RSV Prevention and Treatment American Lung Association
States extend vaccine period as Respiratory Syncytial Virus continues to spread Western Mass News
RSV Is Still Surging in These 9 States, Hitting Kids Under 4 the Hardest. When Will the Season End? TODAY.com
Current and Emerging Strategies for the Prevention of Respiratory Syncytial Virus (RSV) Infections: A Comprehensive Review of Vaccines and Antibody Therapies Cureus
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study The Lancet
How RSV Spreads Centers for Disease Control and Prevention | CDC (.gov)
RSV symptoms in older adults often linger, studies show CIDRAP
The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis Nature
The Evolving Landscape of Respiratory Syncytial Virus (RSV) Prophylaxis in Infants Cureus
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study Nature
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation The Lancet
Short-term environmental changes and respiratory syncytial virus infection in Chile Nature
As RSV spreads at unusually high rates, Pa. and N.J. extend windows for infant immunizations PhillyVoice
Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges Frontiers
Respiratory Syncytial Virus (RSV) Vaccine Safety Centers for Disease Control and Prevention | CDC (.gov)
Immunogenicity and reactogenicity of the adjuvanted respiratory syncytial virus vaccine in patients with chronic kidney disease medRxiv
WHO Health Emergencies EPI-WIN webinar: respiratory syncytial virus (RSV) genomic surveillance – how & why World Health Organization (WHO)
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids CIDRAP
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates CIDRAP
WHO outlines recommendations to protect infants against RSV – respiratory syncytial virus World Health Organization (WHO)
Respiratory syncytial virus (RSV) resources American Medical Association
Respiratory syncytial virus (RSV) tied to heart problems Harvard Health
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest CIDRAP
RSV facts you need to know: What to expect during its winter peak UT Physicians
Protect Yourself from RSV: Who Needs the Vaccine and Why It Matters The National Council on Aging (NCOA)
Hospitalisation and healthcare burden of respiratory syncytial virus in adults over 50 years in France medRxiv
Quick takes: Re-emergent COVID strain, extended US RSV season, typhus in California CIDRAP
RSV tied to heart problems, breathing issues well after infection in adults CIDRAP
RSV Symptoms, Causes & Treatment Cleveland Clinic
Respiratory syncytial virus (RSV) notifications and trends in the transmission cycles from infants and young children to older adults in Ireland: an analysis of incidence shifts over a decade medRxiv